文献リスト

1) Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006; 126: 663-76

2) Aoi T, Yae K, Nakagawa M, et al. Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science. 2008; 321: 699-702

3) Sancho-Bru P, Najimi M, Caruso M, et al. Stem and progenitor cells for liver repopulation: can we standardise the process from bench to bedside？ Gut. 2009; 58: 594-603

4) Overturf K, al-Dhalimy M, Ou CN, et al. Serial transplantation reveals the stem-cell-like regenerative potential of adult mouse hepato­cytes. Am J Pathol. 1997; 151: 1273-80

5) Kofman AV, Morgan G, Kirschenbaum A, et al. Dose- and time-dependent oval cell reaction in acetaminophen-induced murine liver injury. Hepatology. 2005; 41: 1252-61

6) Falkowski O, An HJ, Ianus IA, et al. Regeneration of hepatocyte ‘buds' in cirrhosis from intrabiliary stem cells. J Hepatol. 2003; 39: 357-64

7) Marshall A, Rushbrook S, Davies SE, et al. Relation between hepatocyte G1 arrest, impaired hepatic regeneration, and fibrosis in chronic hepatitis C virus infection. Gastroenterology. 2005; 128: 33-42

8) Crosby HA, Kelly DA, Strain AJ. Human hepatic stem-like cells isolated using c-kit or CD34 can differentiate into biliary epithelium. Gastroenterology. 2001; 120: 534-44

9) Oh SH, Witek RP, Bae SH, et al. Bone marrow-derived hepatic oval cells differentiate into hepatocytes in 2-acetylaminofluorene/partial hepatectomy-induced liver regeneration. Gastroenterology. 2007; 132: 1077-87

10) Alison MR, Poulsom R, Jeffery R, et al. Hepato­cytes from non-hepatic adult stem cells. Nature. 2000; 406: 257

11) Theise ND, Nimmakayalu M, Gardner R, et al. Liver from bone marrow in humans. Hepatology. 2000; 32: 11-6

12) Terai S, Sakaida I, Yamamoto N, et al. An in vivo model for monitoring trans-differentiation of bone marrow cells into functional hepatocytes. J Biochem. 2003; 134: 551-8

13) Sakaida I, Terai S, Yamamoto N, et al. Trans­plantation of bone marrow cells reduces CCl4-induced liver fibrosis in mice. Hepatology. 2004; 40: 1304-11

14) Willenbring H, Bailey AS, Foster M, et al. Myelomonocytic cells are sufficient for therapeu­tic cell fusion in liver. Nat Med. 2004; 10: 744-8

15) Cantz T, Sharma AD, Jochheim-Richter A, et al. Reevaluation of bone marrow-derived cells as a source for hepatocyte regeneration. Cell Transplant. 2004; 13: 659-66

16) Thorgeirsson SS, Grisham JW. Hematopoietic cells as hepatocyte stem cells: a critical review of the evidence. Hepatology. 2006; 43: 2-8

17) Stephenne X, Najimi M, Sibille C, et al. Sustained engraftment and tissue enzyme activity after liver cell transplantation for argininosuccinate lyase deficiency. Gastroenterology. 2006; 130: 1317-23

18) Lee KD, Kuo TK, Whang-Peng J, et al. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology. 2004; 40: 1275-84

19) Sato Y, Araki H, Kato J, et al. Human mesen­chymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood. 2005; 106: 756-63

20) Furst G, Schulte AM, Esch J, et al. Portal vein embolization and autologous CD133＋ bone marrow stem cells for liver regeneration: initial experience. Radiology. 2007; 243: 171-9

21) Mishra L, Banker T, Murray J, et al. Liver stem cells and hepatocellular carcinoma. Hepatology. 2009; 49: 318-29

22) Chiba T, Kita K, Zheng YW, et al. Side population purified from hepatocellular carcinoma cells harbors cancer stem cell-like properties. Hepatology. 2006; 44: 240-51

23) Collins AT, Berry PA, Hyde C, et al. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res. 2005; 65: 10946-51

24) O'Brien CA, Pollett A, Gallinger S, et al. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature. 2007; 445: 106-10

25) Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al. Identification and expansion of human colon-cancer-initiating cells. Nature. 2007; 445: 111-5

26) Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003; 63: 5821-8

27) Singh SK, Hawkins C, Clarke ID, et al. Identifi­cation of human brain tumour initiating cells. Nature. 2004; 432: 396-401

28) Suetsugu A, Nagaki M, Aoki H, et al. Characteri­zation of CD133＋ hepatocellular carcinoma cells as cancer stem/progenitor cells. Biochem Biophys Res Commun. 2006; 351: 820-4

29) Ma S, Chan KW, Hu L, et al. Identification and characterization of tumorigenic liver cancer stem/progenitor cells. Gastroenterology. 2007; 132: 2542-56

30) Yin S, Li J, Hu C, et al. CD133 positive hepato­cellular carcinoma cells possess high capacity for tumorigenicity. Int J Cancer. 2007; 120: 1444-50

31) Ma S, Lee TK, Zheng BJ, et al. CD133＋ HCC cancer stem cells confer chemoresistance by preferential expression of the Akt/PKB survival pathway. Oncogene. 2008; 27: 1749-58

32) Bao S, Wu Q, McLendon RE, et al. Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature. 2006; 444: 756-60

33) Liu G, Yuan X, Zeng Z, et al. Analysis of gene expression and chemoresistance of CD133＋ cancer stem cells in glioblastoma. Mol Cancer. 2006; 5: 67

34) Takai A, Toyoshima T, Uemura M, et al. A novel mouse model of hepatocarcinogenesis triggered by AID causing deleterious p53 mutations. Oncogene. 2009; 28: 469-78

35) Kitisin K, Ganesan N, Tang Y, et al. Disruption of transforming growth factor-beta signaling through beta-spectrin ELF leads to hepatocellular cancer through cyclin D1 activation. Oncogene. 2007; 26: 7103-10

36) Tang Y, Kitisin K, Jogunoori W, et al. Progenitor/stem cells give rise to liver cancer due to aberrant TGF-beta and IL-6 signaling. Proc Natl Acad Sci U S A. 2008; 105: 2445-50

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp